Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Net Margin (2016 - 2025)

Historic Net Margin for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to 8.69%.

  • Bristol Myers Squibb's Net Margin rose 80700.0% to 8.69% in Q4 2025 from the same period last year, while for Dec 2025 it was 14.64%, marking a year-over-year increase of 333700.0%. This contributed to the annual value of 14.64% for FY2025, which is 331400.0% up from last year.
  • Bristol Myers Squibb's Net Margin amounted to 8.69% in Q4 2025, which was up 80700.0% from 17.96% recorded in Q3 2025.
  • Bristol Myers Squibb's Net Margin's 5-year high stood at 21.98% during Q1 2025, with a 5-year trough of 100.36% in Q1 2024.
  • Over the past 5 years, Bristol Myers Squibb's median Net Margin value was 13.85% (recorded in 2022), while the average stood at 8.4%.
  • In the last 5 years, Bristol Myers Squibb's Net Margin tumbled by -1203600bps in 2024 and then soared by 1223400bps in 2025.
  • Bristol Myers Squibb's Net Margin (Quarter) stood at 19.79% in 2021, then fell by -10bps to 17.75% in 2022, then dropped by -14bps to 15.35% in 2023, then crashed by -96bps to 0.62% in 2024, then soared by 1311bps to 8.69% in 2025.
  • Its Net Margin stands at 8.69% for Q4 2025, versus 17.96% for Q3 2025 and 10.7% for Q2 2025.